Issues with the Specificity of Immunological Reagents for NLRP3: Implications for Age-related Macular Degeneration-Reference-Cited by-同舟云学术

Issues with the Specificity of Immunological Reagents for NLRP3: Implications for Age-related Macular Degeneration

Published:2018-01-11 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Kosmidou Cassandra,Efstathiou Nikolaos E.,Hoang Mien V.,Notomi Shoji,Konstantinou Eleni K.,Hirano Masayuki,Takahashi Kosuke,Maidana Daniel E.^ORCID,Tsoka Pavlina,Young Lucy,Gragoudas Evangelos S.,Olsen Timothy W.,Morizane Yuki,Miller Joan W.^ORCID,Vavvas Demetrios G.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-17634-1.pdf

Reference56 articles.

1. World Health Organization. Prevention of Blindness and Visual Impairment http://www.who.int/blindness/causes/priority/en/ (2017).

2. Wong, W. L. et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2, e106–116, https://doi.org/10.1016/S2214-109X(13)70145-1 (2014).

3. Miller, J. W. VEGF: From Discovery to Therapy: The Champalimaud Award Lecture. Transl Vis Sci Technol 5, 9, https://doi.org/10.1167/tvst.5.2.9 (2016).

4. Rosenfeld, P. J. et al. Ranibizumab for Neovascular Age-Related Macular Degeneration. N Eng J Med 355, 1419–1431, https://doi.org/10.1056/NEJMoa054481 (2006).

5. Deangelis, M. M., Silveira, A. C., Carr, E. A. & Kim, I. K. Genetics of age-related macular degeneration: current concepts, future directions. Semin Ophthalmol 26, 77–93, https://doi.org/10.3109/08820538.2011.577129 (2011).

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NLRP3 and autophagy in retinal ganglion cell inflammation in age-related macular degeneration: potential therapeutic implications;International Journal of Ophthalmology;2024-08-18

2. The contribution of pattern recognition receptor signalling in the development of age related macular degeneration: the role of toll-like-receptors and the NLRP3-inflammasome;Journal of Neuroinflammation;2024-03-05

3. Repurposing medications for treatment of age-related macular degeneration: Insights from novel approaches to data mining;Experimental Biology and Medicine;2023-05

4. Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial;Eye;2023-03-24

5. The NLRP3 inflammasome – interleukin 1β axis in uveal melanoma;FEBS Open Bio;2023-02-12